Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Manufacturers Should Expect No Relief From China’s Rising API Prices

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - API prices in China have increased since the end of last year, and prices are expected to continue to rise with the addition of new costs associated with stronger environmental protection standards, according to analysts

You may also be interested in...



Vietnam To Boost Pharma Industry; Key MOU Signed Between Ministries

Vietnam's Ministry of Public Health and the Ministry of Industry and Trade signed a memorandum of understanding to develop the country's pharmaceutical industry and stabilize the country's pharmaceutical market

Vietnam To Boost Pharma Industry; Key MOU Signed Between Ministries

Vietnam's Ministry of Public Health and the Ministry of Industry and Trade signed a memorandum of understanding to develop the country's pharmaceutical industry and stabilize the country's pharmaceutical market

China Shenghuo Sees Sales Boost In Rural Markets From New Health Care Reform And Expanding Retail Cosmetics

SHANGHAI - China Shenghuo Pharmaceutical saw sales growth in China's rural areas thanks to new medical reforms in China during the first nine months of 2008, company President Lan Feng told a Nov. 25 earnings call

Related Content

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel